Issue 029.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a glass-is-more-than-half-full 55 percent open rate. Here's what's happening this week:

• I spent most of Thursday just outside of Washington DC at a workshop convened by IEEE and US Pharmacopeia focused on thinking through standards for smart pills -- sometimes called digital pills, signaling pills, or as FDA-savvy lawyers call them, ingestible event markers. A few initial thoughts and findings from that below.
• This slide deck and these presentation notes from Princeton University computer science professor Arvind Narayanan make for a great primer on how to cut through AI hype. It's not healthcare-specific but references some medical use cases. He breaks down AI claims into the genuine, the far from perfect but improving, and the dubious.
• You probably read this